You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cryptophycin 52

Showing 1 - 25 of 1,540
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension Trial in Seoul (C52R1M Tab. and C52R2 Tab., AJU-C52H)

Recruiting
  • Hypertension
  • Seoul, Republic Of South Korea, Korea, Republic of
    H+ Yangji Hospital
Oct 1, 2021

Hypertension Trial in Seoul (C52R1H Tab. and C52R2 Tab., AJU-C52L)

Recruiting
  • Hypertension
  • Seoul, Republic Of South Korea, Korea, Republic of
    H+ Yangji Hospital
Oct 1, 2021

BESPONSA Injection 1 mg Special Investigation

Active, not recruiting
  • Acute Lymphocytic Leukemia
    • Tokyo, Japan
      Pfizer
    Jun 20, 2023

    T2DM (Type 2 Diabetes) Trial (DWP16001 0.3 mg)

    Not yet recruiting
    • T2DM (Type 2 Diabetes Mellitus)
    • DWP16001 0.3 mg
    • (no location specified)
    Nov 15, 2023

    Peripheral Neuropathic Pain Trial in Beijing (HSK16149 40mg BID)

    Active, not recruiting
    • Peripheral Neuropathic Pain
    • HSK16149 40mg BID
    • Beijing, Beijing, China
      Peking University First Hospital
    May 24, 2023

    Nephrotic Syndrome in Children, Telitacicept Trial in Hangzhou (Telitacicept)

    Recruiting
    • Nephrotic Syndrome in Children
    • Telitacicept
    • Hangzhou, Zhejiang, China
      Children's Hospital, Zhejiang University School of Medicine
    Nov 8, 2023

    Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement Trial in El Paso (Vixarelimab, Placebo)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Systemic Sclerosis With Lung Involvement
    • El Paso, Texas
      El Paso Pulmonary Association Elligo PPDS
    Mar 14, 2023

    Progressive Pulmonary Fibrosis, Interstitial Lung Disease Trial (Placebo, Inhaled Treprostinil, Treprostinil Ultrasonic

    Not yet recruiting
    • Progressive Pulmonary Fibrosis
    • Interstitial Lung Disease
    • Placebo
    • +2 more
    • (no location specified)
    Jul 5, 2023

    Nonalcoholic Steatohepatitis Trial in Worldwide (MK-3655, Placebo)

    Active, not recruiting
    • Nonalcoholic Steatohepatitis
    • Tucson, Arizona
    • +179 more
    Jan 19, 2023

    Special Drug Use Surveillance of Entresto Tablets (Hypertension)

    Not yet recruiting
    • Hypertension
    • (no location specified)
    Jul 28, 2023

    INCHANGE - Nintedanib for Changes in Cough and Dyspnea in

    Not yet recruiting
    • Lung Diseases, Interstitial
    • (no location specified)
    Aug 19, 2022

    Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)

    Recruiting
    • Nonvalvular Atrial Fibrillation
    • Angers, France
      Angers University Hospital
    Jul 25, 2022

    Non-segmental Vitiligo (Both Active and Stable Vitiligo) Trial in Canada, Japan, United States (Ritlecitinib, Placebo)

    Recruiting
    • Non-segmental Vitiligo (Both Active and Stable Vitiligo)
    • Huntington Beach, California
    • +16 more
    Jan 18, 2023

    Novel Antidiabetic Medications and Their Effect on Liver

    Completed
    • Non-Alcoholic Fatty Liver Disease
    • Liver Steatosis
    • Athens, Attiki, Greece
      "Hippocration" General Hospital of Athens
    Jul 13, 2023

    Achondroplasia Trial (TransCon CNP, Placebo for TransCon CNP)

    Not yet recruiting
    • Achondroplasia
    • TransCon CNP
    • Placebo for TransCon CNP
    • (no location specified)
    Jan 11, 2023

    INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients

    Recruiting
    • Lung Diseases, Interstitial
    • Aachen, Germany
    • +19 more
    Jul 26, 2022

    Colitis Ulcerative Trial in Miami Lakes, Charlotte (Dupilumab, Placebo)

    Recruiting
    • Colitis Ulcerative
    • Miami Lakes, Florida
    • +1 more
    Feb 15, 2023

    Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

    Recruiting
    • Atopic Dermatitis Eczema
    • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
    • Birmingham, Alabama
    • +91 more
    Jan 26, 2023

    Distal Lateral Subungual Onychomycosis, Onychomycosis Trial in United States (Nail Genesis DLSO Product, Nail Genesis DLSO

    Recruiting
    • Distal Lateral Subungual Onychomycosis
    • Onychomycosis
    • Nail Genesis DLSO Product
    • Nail Genesis DLSO Product (vehicle only)
    • Fayetteville, Arkansas
    • +9 more
    Oct 9, 2023

    Nephrotic Syndrome in Children, Rituximab Trial in Hangzhou (Rituximab, Steroid)

    Not yet recruiting
    • Nephrotic Syndrome in Children
    • Rituximab
    • Hangzhou, Zhejiang, China
      Children's Hospital, Zhejiang University School of Medicine
    Feb 9, 2023

    Moderate-to-severe Plaque Psoriasis Patients Response to

    Completed
    • Moderate-to-severe Plaque Psoriasis
      • Jakarta, Indonesia
        Mangga Besar Clinic
      Mar 15, 2023

      Non-erosive Reflux Disease, Erosive Esophagitis Trial in United States (BLI5100)

      Enrolling by invitation
      • Non-erosive Reflux Disease
      • Erosive Esophagitis
      • Huntsville, Alabama
      • +20 more
      May 25, 2023

      Postoperative Residual Neuromuscular Blockade in Era of

      Not yet recruiting
      • Postoperative Residual Curarization
      • (no location specified)
      Feb 26, 2023

      Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid))

      Recruiting
      • Hyper-low-density Lipoprotein (LDL) Cholesterolemia
      • 180mg of ETC-1002(bempedoic acid)
      • Izumisano-shi, Japan
        Rinku General Medical Center
      Jan 13, 2023

      Schizophrenia, Bipolar I Disorder Trial in DeSoto (Iloperidone)

      Recruiting
      • Schizophrenia
      • Bipolar I Disorder
      • DeSoto, Texas
        Vanda Investigational Site
      Dec 5, 2022